Gideon Capital Advisors’s Amgen AMGN Stock Holding History

Gideon Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,525	Closed	-$480K	–	265
2019 Q1	$480K	Buy	+2,525	New	+$482K	0.17%	177
2018 Q4	–	Sell	-2,412	Closed	-$500K	–	364
2018 Q3	$500K	Sell	2,412 -643	-21%	-$127K	0.24%	144
2018 Q2	$564K	Buy	3,055 +1,001	+49%	+$177K	0.28%	111
2018 Q1	$350K	Sell	2,054 -1,932	-48%	-$355K	0.22%	192
2017 Q4	$693K	Buy	3,986 +1,259	+46%	+$223K	0.61%	29
2017 Q3	$508K	Buy	2,727 +1,329	+95%	+$235K	0.5%	44
2017 Q2	$241K	Sell	1,398 -2,014	-59%	-$328K	0.27%	182
2017 Q1	$560K	Buy	3,412 +786	+30%	+$131K	0.33%	82
2016 Q4	$384K	Buy	+2,626	New	+$395K	0.25%	156
2015 Q3	–	Sell	-2,795	Closed	-$429K	–	214
2015 Q2	$429K	Buy	+2,795	New	+$448K	0.18%	147
2014 Q3	–	Sell	-2,232	Closed	-$264K	–	264
2014 Q2	$264K	Buy	+2,232	New	+$258K	0.1%	209

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gideon Capital Advisors's AMGN Position: Q2 2019 in Review

Gideon Capital Advisors sold out of Amgen (AMGN) in Q2 2019, closing a stake of 2,525 shares — an estimated $480K sold.

Gideon Capital Advisors first reported a position in AMGN in Q2 2014 and held it in 11 quarters. The position peaked at $693K in Q4 2017. 1,865 funds tracked by Wall St. Rank hold AMGN as of Q2 2019.

Gideon Capital Advisors reported no remaining Amgen position as of Q2 2019 after selling out during the quarter.
Gideon Capital Advisors sold 2,525 Amgen shares in Q2 2019, an estimated $480K.
Gideon Capital Advisors first reported a position in Amgen in Q2 2014 and held it in 11 quarters.
Gideon Capital Advisors's Amgen position peaked at $693K in Q4 2017.
1,865 funds tracked by Wall St. Rank held Amgen as of Q2 2019.

Based on Gideon Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.